Universe · entity
Venrock Adviser, LLC
Institutional manager (13F) · CIK 1615982
13F holdings · as of 2026-03-31 · top 33 · reported portfolio $2.7B
| # | Issuer | Value | Shares |
|---|---|---|---|
| 1 | <![CDATA[APOGEE THERAPEUTICS INC]]> | $715M | 8,493,321 |
| 2 | <![CDATA[ERASCA INC]]> | $265M | 16,382,812 |
| 3 | <![CDATA[ORUKA THERAPEUTICS INC]]> | $203M | 4,148,428 |
| 4 | <![CDATA[SPYRE THERAPEUTICS INC]]> | $186M | 3,685,448 |
| 5 | <![CDATA[KALVISTA PHARMACEUTICALS INC]]> | $130M | 6,474,485 |
| 6 | <![CDATA[DIANTHUS THERAPEUTICS INC]]> | $99M | 1,180,000 |
| 7 | <![CDATA[DAMORA THERAPEUTICS INC]]> | $93M | 3,603,595 |
| 8 | <![CDATA[OCULAR THERAPEUTIX INC]]> | $88M | 10,346,926 |
| 9 | <![CDATA[COGENT BIOSCIENCES INC]]> | $77M | 2,000,000 |
| 10 | <![CDATA[VIRIDIAN THERAPEUTICS INC]]> | $76M | 3,882,709 |
| 11 | <![CDATA[SAVARA INC]]> | $75M | 13,740,375 |
| 12 | <![CDATA[ENLIVEN THERAPEUTICS INC]]> | $68M | 1,726,331 |
| 13 | <![CDATA[ORIC PHARMACEUTICALS INC]]> | $55M | 4,319,765 |
| 14 | <![CDATA[VOR BIOPHARMA INC]]> | $54M | 3,041,719 |
| 15 | <![CDATA[MAZE THERAPEUTICS INC]]> | $48M | 1,602,034 |
| 16 | <![CDATA[CYTOMX THERAPEUTICS INC]]> | $47M | 9,982,124 |
| 17 | <![CDATA[JADE BIOSCIENCES INC]]> | $45M | 3,220,364 |
| 18 | <![CDATA[DYNE THERAPEUTICS INC]]> | $39M | 2,173,913 |
| 19 | <![CDATA[CRESCENT BIOPHARMA INC.]]> | $39M | 2,133,576 |
| 20 | <![CDATA[ZURA BIO LTD]]> | $38M | 6,434,990 |
| 21 | <![CDATA[RELMADA THERAPEUTICS INC]]> | $34M | 4,843,380 |
| 22 | <![CDATA[ENGENE HOLDINGS INC]]> | $32M | 4,771,414 |
| 23 | <![CDATA[TENAX THERAPEUTICS INC]]> | $27M | 1,675,262 |
| 24 | <![CDATA[ADLAI NORTYE LTD]]> | $22M | 3,212,731 |
| 25 | <![CDATA[CENTURY THERAPEUTICS INC]]> | $20M | 8,695,652 |
| 26 | <![CDATA[CULLINAN THERAPEUTICS INC]]> | $20M | 1,379,965 |
| 27 | <![CDATA[CYBIN INC]]> | $18M | 3,851,654 |
| 28 | <![CDATA[SURROZEN INC]]> | $18M | 632,931 |
| 29 | <![CDATA[SEPTERNA INC]]> | $12M | 506,056 |
| 30 | <![CDATA[KORRO BIO INC]]> | $11M | 1,009,500 |
| 31 | <![CDATA[ALTO NEUROSCIENCE INC]]> | $11M | 500,000 |
| 32 | <![CDATA[ARTIVA BIOTHERAPEUTICS INC]]> | $10M | 1,609,569 |
| 33 | <![CDATA[X4 PHARMACEUTICALS INC]]> | $1M | 330,525 |
Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.